Current Research Studies
Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL-2 Study)
FUEL-2
What is the goal of the study?
To evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of phosphodiesterase type 5 (PDE5), versus placebo for the treatment of adolescent subjects who have undergone the Fontan procedure.
Who can participate in the study?
Please contact the study team listed below to learn more.